CAR-T therapies face logistical bottleneck as market set to see major growth

0
18
T-cells attacking cancer cell illustration of microscopic photosT-cells attacking cancer cell illustration of microscopic photos


Experts say proliferation of products makes standardization crucial, as ballooning complexity risks overwhelming apheresis centers and forcing service cuts.



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here